Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,850 | -12,328 | -8,810 | -5,795 | -14,145 |
| Depreciation Amortization | 58 | 41 | 28 | 14 | 45 |
| Accounts payable and accrued liabilities | -711 | 49 | -656 | 9 | 841 |
| Other Working Capital | -1,768 | -402 | -275 | 932 | 1,594 |
| Other Operating Activity | 5,037 | 3,437 | 3,297 | 1,698 | 2,612 |
| Operating Cash Flow | $-12,234 | $-9,203 | $-6,416 | $-3,142 | $-9,053 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,091 | -546 | 3 | -1,497 | 3 |
| PPE Investments | -75 | -76 | N/A | N/A | -195 |
| Investing Cash Flow | $-2,166 | $-622 | $3 | $-1,497 | $-192 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -284 | -260 | -260 | -46 | -46 |
| Financing Cash Flow | $-284 | $-260 | $-260 | $-46 | $-46 |
| Beginning Cash Position | 31,299 | 31,299 | 31,299 | 31,299 | 40,590 |
| End Cash Position | 16,615 | 21,214 | 24,626 | 26,614 | 31,299 |
| Net Cash Flow | $-14,684 | $-10,085 | $-6,673 | $-4,685 | $-9,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,234 | -9,203 | -6,416 | -3,142 | -9,053 |
| Capital Expenditure | -75 | -76 | N/A | N/A | -195 |
| Free Cash Flow | -12,309 | -9,279 | -6,416 | -3,142 | -9,248 |